Perspective Therapeutics Inc (CATX)
Cost of Revenue
$0.00
Quarterly · Period ending: · USD
CATX Cost of Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
CATX Quarterly Cost of Revenue ($0.00 → $0.00)
Quarterly cost of revenue
High-resolution chart · PNG
CATX cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 0 | |
| 1,126,000 | |
| 0 | |
| 775,000 | |
| 733,000 | |
| 669,000 | |
| 0 | |
| 0 | |
| 356,000 | |
| 209,000 | |
| 0 | |
| 1,840,000 | |
| 5,370,000 | |
| 1,576,000 | |
| 1,432,000 | |
| 1,303,000 | |
| 1,579,000 | |
| 1,469,000 | |
| 1,596,000 | |
| 1,535,000 | |
| 1,364,000 | |
| 1,238,000 | |
| 1,192,000 | |
| 1,138,000 | |
| 1,208,000 | |
| 1,174,000 | |
| 1,095,000 | |
| 1,079,000 | |
| 1,045,000 | |
| 1,045,000 | |
| 1,139,000 | |
| 1,038,000 | |
| 1,166,000 | |
| 964,000 | |
| 1,005,000 | |
| 946,000 | |
| 872,000 | |
| 989,000 | |
| 1,029,000 | |
| 1,033,000 | |
| 1,167,765 | |
| 1,132,397 | |
| 1,162,097 | |
| 1,177,863 | |
| 1,135,782 | |
| 1,102,912 | |
| 1,103,549 | |
| 1,096,903 | |
| 1,085,679 | |
| 1,083,413 | |
| 1,119,314 | |
| 1,127,223 | |
| 1,098,743 | |
| 1,065,574 | |
| 1,134,083 | |
| 1,076,657 | |
| 1,077,902 | |
| 1,113,151 | |
| 1,029,757 | |
| 1,147,075 | |
| 799,756 | |
| 1,053,268 | |
| 1,117,005 | |
| 1,111,527 | |
| 1,149,275 | |
| 1,150,730 | |
| 1,100,193 | |
| 1,160,089 | |
| 1,247,442 | |
| 1,351,044 | |
| 1,724,225 | |
| 1,448,436 | |
| 1,379,846 | |
| 1,682,981 | |
| 2,241,795 | |
| 2,005,502 | |
| 1,660,112 | |
| 1,456,978 | |
| 1,387,394 | |
| 1,288,145 | |
| 1,387,225 | |
| 791,457 | |
| 916,274 | |
| 720,166 | |
| 720,166 | |
| 520,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |